EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

ASXL3‐related disorder: Molecular phenotyping and comprehensive review providing insights into disease mechanism

Emily Woods iD, Nicola Holmes, Shadi Albaba, Iwan R Evans iD, Meena Balasubramanian iD

Clinical Genetics · 2024

DOI: 10.1111/cge.14506 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Genetics, 2024. Verfasst von Emily Woods und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK. Hauptthemen laut MEDLINE: Developmental Disabilities, Intellectual Disability, Abnormalities, Multiple, Facies. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ASXL3‐related disorder, sometimes referred to as Bainbridge‐Ropers syndrome, was first identified as a distinct neurodevelopmental disorder by Bainbridge et al. in 2013. Since then, there have been a number of case series and single case reports published worldwide. A comprehensive review of the literature was carried out. Abstracts were screened, relevant literature was analysed, and descriptions of common phenotypic features were quantified. ASXL3 variants were collated and categorised. Common phenotypic features comprised global developmental delay or intellectual disability (97%), feeding problems (76%), hypotonia (88%) and characteristic facial features (93%). The majority of genetic variants were de novo truncating variants in exon 11 or 12 of the ASXL3 gene. Several gaps in our knowledge of this disorder were identified, namely, underlying pathophysiology and disease mechanism, disease contribution of missense variants, relevance of variant location, prevalence and penetrance data. Clinical information is currently limited by patient numbers and lack of longitudinal data, which this review aims to address.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Developmental DisabilitiesIntellectual DisabilityAbnormalities, MultipleFaciesNeurodevelopmental DisordersChildHumansTranscription FactorsPhenotypeSyndromeRepressor Proteins

Stichwörter der Autor:innen

ASXL3Bainbridge‐Ropers syndromeDrosophila melanogasterneurodevelopmental disorder

Substanzen

Bainbridge-Ropers syndromeTranscription FactorsASXL3 protein, humanRepressor Proteins

Autor:innen und Institutionen

  • Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK.
  • Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
  • Sheffield Diagnostic Genetics Service, Sheffield Children's Hospital, Sheffield, UK.
  • The Bateson Centre, University of Sheffield, Sheffield, UK.

ORCID-Profile: Emily Woods, Iwan R Evans, Meena Balasubramanian

Förderung

  • Medical Research Council

Zitieren

APA

Woods, E., Holmes, N., Albaba, S., Evans, I. R., & Balasubramanian, M. (2024). ASXL3‐related disorder: Molecular phenotyping and comprehensive review providing insights into disease mechanism. Clinical Genetics. https://doi.org/10.1111/cge.14506

Vancouver

Woods E, Holmes N, Albaba S, Evans IR, Balasubramanian M. ASXL3‐related disorder: Molecular phenotyping and comprehensive review providing insights into disease mechanism. Clinical Genetics. 2024. doi:10.1111/cge.14506

BibTeX
@article{Woods2024,
  author = {Woods, Emily and Holmes, Nicola and Albaba, Shadi and Evans, Iwan R and Balasubramanian, Meena},
  title = {ASXL3‐related disorder: Molecular phenotyping and comprehensive review providing insights into disease mechanism},
  journal = {Clinical Genetics},
  year = {2024},
  doi = {10.1111/cge.14506}
}
Kostenlos starten →